Phenoxybenzamine in the treatment of causalgia. Report of 40 cases.
Forty consecutive cases of causalgia treated during a 7-year period are presented. The patients ranged in age between 17 and 55 years, and all patients were males who received their nerve injuries from missile or shrapnel wounds. The greater occipital nerve was involved in two cases, median nerve in 10, sciatic nerve in 12, brachial plexus in seven, cauda equina in five, and multiple nerves in four cases. Each patient was treated with phenoxybenzamine, a postsynaptic alpha 1-blocker and presynaptic alpha 2-blocking agent. The drug was given orally in gradually increasing increments until a maximum daily dose of 40 to 120 mg was reached. Duration of treatment was usually 6 to 8 weeks. Total resolution of pain was achieved in all cases. The follow-up period ranged between 6 months and 6 years. Side effects of phenoxybenzamine were minimal and transient, consisting primarily of mild orthostatic hypotension and ejaculatory problems. We conclude that oral phenoxybenzamine is a simple, safe, and effective treatment of causalgia.
D000293:Adolescent; D000328:Adult; D002422:Causalgia / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D004542:Ejaculation / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy*; D010643:Phenoxybenzamine / Q000009:adverse effects / Q000627:therapeutic use*; D014948:Wounds, Gunshot / Q000150:complications
D010643:Phenoxybenzamine